Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)
Phase 2
Recruiting
- Conditions
- Chronic Rhinosinusitis (Diagnosis)
- Interventions
- Device: Pre-filled syringe and applicator device
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Oticara Australia PTY LTD
- Target Recruit Count
- 24
- Registration Number
- NCT05882903
- Locations
- 🇦🇺
Oticara Investigational Site, Perth, Western Australia, Australia
Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream
Phase 1
Terminated
- Conditions
- Chronic Rhinosinusitis (Diagnosis)
- Interventions
- Device: Pre-filled syringe and applicator device
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Oticara Australia PTY LTD
- Target Recruit Count
- 2
- Registration Number
- NCT05220293
- Locations
- 🇦🇺
Oticara Clinical Trial Site, Sydney, New South Wales, Australia
News
No news found